Overview of (1->3)-beta-D-glucan immunobiology

By Williams David L.  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 247-250

Informa Healthcare

Access to resources Recommend Favorite

(1->3)-beta-D-glucan in patients with pulmonary aspergilloma

By Yuasa Kazumi   Goto Hajime  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 285-287

Informa Healthcare

Access to resources Recommend Favorite

Pharm acokinetics, biological effects, and distribution of (1->3)-beta-D-glucan in blood and organs in rabbits

By Yoshida Minoru   Roth Robert I.   Grunfeld Carl   Feingold Kenneth R.   Levin Jack  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 279-283

Informa Healthcare

Access to resources Recommend Favorite

Inhalation toxicity of (1->3)-beta-D glucan: recent advances

By Fogelmark Birgitta   Sjostrand Margareta   Williams David   Rylander Ragnar  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 263-265

Informa Healthcare

Access to resources Recommend Favorite

Inhalation of (1→3)-β-D-glucan causes airway eosinophilia

By Fogelmark Birgitta   Thorn Jörgen   Rylander Ragnar  

Mediators of Inflammation, Vol. 10, Iss. 1, 2001-02 ,pp. : 13-19

Informa Healthcare

Access to resources Recommend Favorite